| Structure | Chemical Name | CAS | MF |
|
NTF97 (Nuclear Transport Factor p97)
|
|
|
|
|
NTF97 (Nuclear Transport Factor p97) (A)
|
|
|
|
|
nsP3 protein
|
|
|
|
|
NSP protein
|
|
|
|
|
Ntf3 protein
|
|
|
|
|
NSP116 protein
|
|
|
|
|
NSP1 protein, rotavirus
|
|
|
|
|
NSP1 protein
|
|
|
|
|
nsP2 proteinase
|
|
|
|
|
NSP49 protein
|
|
|
|
|
NSP6 protein, rotavirus group A
|
|
|
|
|
NSP5 protein, rotavirus group A
|
|
|
|
|
nsP1 protein, Sindbis virus
|
|
|
|
|
nsP4 protein
|
|
|
|
|
NTH-1
|
|
|
|
|
NTH-2
|
|
|
|
|
NTH-3
|
|
|
|
|
Ns4 protein (mouse hepatitis virus)
|
|
|
|
|
NS1 protein, flavivirus
|
|
|
|
(+)-N-[(S)-1-Propylpentyl]benzamide
|
|
C15H23NO
|
|
|
NS4 protein, hepatitis C virus
|
|
|
|
|
NS-5 protein, hepatitis C virus
|
|
|
|
|
NS2-3 protease
|
|
|
|
|
NSP4 serine protease
|
|
|
|
|
NS1 protein, parvovirus
|
|
|
|
|
NS2 protein, epizootic hemorrhagic disease virus
|
|
|
|
|
NS2 protein, hepatitis C virus
|
|
|
|
|
NS3 protein, African horse sickness virus
|
|
|
|
|
NS1 protein, minute virus of mice
|
|
|
|
|
NS1 protein, African horsesickness virus
|
|
|
|
|
NS Protease Inhibitor
|
|
|
|
|
NS1 protein, bluetongue virus
|
|
|
|
|
NS1 protein, dengue-1 virus
|
|
|
|
|
NS3 protein, flavivirus
|
|
|
|
|
NS35 protein, rotavirus
|
138414-65-0
|
|
|
|
NS3 protein, hepatitis C virus
|
|
|
|
|
NS5 protein, flavivirus
|
|
|
|
|
(-)-N-[(S)-α-(p-Toluenesulfonyloxymethyl)phenethyl]-p-toluenesulfonamide
|
|
|
|
(-)-N-[(S)-1-(p-Toluenesulfonyloxymethyl)-3-methylbutyl]-p-toluenesulfonamide
|
|
C20H27NO5S2
|
|
|
(-)-N-[(S)-α-(p-Tolylsulfonyloxymethyl)-p-(p-tolylsulfonyloxy)phenethyl]-p-toluenesulfonamide
|
|
|
|
|
(-)-N-[(S)-α-(p-Toluenesulfonyloxymethyl)-3,4-dimethoxyphenethyl]-p-toluenesulfonamide
|
|
|
|
(-)-N-[(S)-1-(p-Toluenesulfonyloxymethyl)-2-methylpropyl]-p-toluenesulfonamide
|
|
C19H25NO5S2
|
|
|
(+)-N-[(S)-α-(p-Toluenesulfonyloxymethyl)benzyl]-p-toluenesulfonamide
|
|
|
|
(-)-N-[(S)-1-(p-Toluenesulfonyloxymethyl)-3-phenylpropyl]-p-toluenesulfonamide
|
|
C24H27NO5S2
|
|
|
ntf1+ transcription factor
|
155982-33-5
|
|
|
|
N-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]-PPA-NH2
|
|
|
|
(-)-N-[(2S, 3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTYRYL]-L-LEUCINE METHYL ESTER
|
65322-89-6
|
C17H26N2O4
|
|
N-[(2S,3R)-3-Amino-2-hydroxy-4-[2-[(2-nitrophenyl)thio]-1H-indol-3-yl]butyryl]-L-leucine
|
|
C24H28N4O6S
|
|
N2-[(2S,3R)-3-Amino-2-hydroxy-4-[2-[(2-nitrophenyl)thio]-1H-indol-3-yl]butyryl]-L-lysine
|
|
C24H29N5O6S
|
|
N2-[(2S,3R)-3-Amino-2-hydroxy-4-[2-[(2-nitrophenyl)thio]-1H-indol-3-yl]butyryl]-D-lysine
|
|
C24H29N5O6S
|
|
|
N-[2-[1-[[3-[[(1S,4R)-Bicyclo[2.2.1]hept-5-en-2β-yl]methyl]ureido]sulfonyl]-4-piperidinyl]ethyl]-2-methoxy-3-pyridinecarboxamide
|
|
|
|
N-[(1S)-1-[[[(2R)-Bicyclo[2.2.1]heptan-2-yl][[[1-(trifluoroacetyl)-2-methylpropyl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide
|
|
C34H40ClF3N4O7S
|
|
N-[(2S,4R)-4-(BIPHENYL-2-YLMETHYL-ISOBUTYL-AMINO)-1-[2-(2,4-DIFLUOROBENZOYL)-BENZOYL]-PYRROLIDIN-2-YLMETHYL]-3-[4-(2,4-DIOXOTHIAZOLIDIN-5-YLIDENEMETHYL)-PHENYL]ACRYLAMIDE, HCL
|
|
C49H45ClF2N4O5S
|
|
N6-[((1S,2R)-1-CARBOXY-2-HYDROXYBUTYLAMINO)CARBONYL]ADENOSINE SODIUM SALT
|
24719-82-2
|
C15H20N6O8
|
|
N-[(1S,4R)-10-CAMPHORSULPHONYL]-(1R, 2R)-1, 2-DIPHENYLETHYLENEDIAMINE
|
|
C24H30N2O3S
|
|
|
N-[(S)-2-[[(R)-1-[(Cbz-L-Ala-L-Ala-)Amino]-3-methylbutyl]phosphonyloxy]-3-phenylpropionyl]-L-Ala-L-Ala-OMe
|
|
|
|
|
NTGLO protein
|
|
|
|
N-[(1S,2R)-2-(4-Chlorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-(trifluoromethyl)benzamide
|
|
C20H18ClF3N4O2
|
|
N-[(1S,2R)-2-Bromo-1,2-diphenylethyl]acetamide
|
|
C16H16BrNO
|
|
1-[N-[[(1S,2R)-2-[(DiethylaMino)carbonyl]-2-phenylcyclopropyl]Methyl]carbaMate]-β-D-glucopyranuronic Acid 2,3,4-Triacetate Methyl Ester
|
|
C29H38N2O12
|
|
N-[(1S,5R)-7,9-dimethyl-7,9-diazabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide dihydrochloride
|
160472-97-9
|
C17H24ClN5O
|
|
|
NTH1 (E. coli Endonuclease III Homologue)
|
|
|
|
N-[(3S,4R)-6-CYANO-3,4-DIHYDRO-3-HYDROXY-2,2-DIMETHYL-2H-1-BENZOPYRAN-4-YL]-N-HYDROXYACETAMIDE
|
127408-31-5
|
C14H16N2O4
|
|
N-[(3S,4R)-6-CYANO-3,4-DIHYDRO-3-HYDROXY-2,2-DIMETHYL-2H-1-BENZOPYRAN-4-YL]-N-(PHENYLMETHOXY)ACETAMIDE
|
127408-30-4
|
C21H22N2O4
|
|
N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-Hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-13-(1-oxopropoxy)-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetrene-2-yl]-2-oxopropanamide
|
28268-50-0
|
|
|
N-[S-[(1R,2E,4E,6E)-1-[(1S)-1-Hydroxy-4-carboxybutyl]-2,4,6-dodecatrien-1-yl]-L-cysteinyl]glycine
|
|
C22H36N2O6S
|
|
N-[S-[(1R,2E,4E,6E)-1-[(1S)-1-Hydroxy-4-carboxybutyl]-2,4,6-octatrien-1-yl]-L-cysteinyl]glycine
|
|
C18H28N2O6S
|
|
N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-(Acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide
|
23812-97-7
|
C27H35NO8
|
|
N-[S-[(1R,2E,4E,6E,9Z)-1-(Hydroxymethyl)-2,4,6,9-pentadecatetren-1-yl]-L-cysteinyl]glycine
|
|
C21H34N2O4S
|
|
N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-Hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-13-(ethoxycarbonyl)-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide
|
|
C28H37NO8
|
|
N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-tricosanamide
|
67605-84-9
|
C41H81NO3
|
|
|
NTH (Endonuclease III Like 1, NTHL1, OCTS3)
|
|
|
|
N-(2-Thenyl)carbamic acid 2-hydroxyethyl ester
|
|
C8H11NO3S
|
|
N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide
|
4201-62-1
|
C46H87NO13
|
|
N-[(3S)-pyrrolidin-3-ylMethyl]acetaMide
|
1225062-98-5
|
C7H14N2O
|
|
N-(S)-1-Pyrrolidin-2-ylMethyl-acetaMide
|
345347-89-9
|
C7H14N2O
|
|
(-)-N-[(S)-1-(4-Pyridyl)ethyl]acetamide
|
|
C9H12N2O
|
|
(-)-N-[(S)-1-(3-Pyridyl)ethyl]acetamide
|
|
C9H12N2O
|
|
(-)-N-[(S)-1-(2-Pyridyl)ethyl]acetamide
|
|
C9H12N2O
|
|
N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-5-((2S,3R,4R,5R,6R)-3-ethanamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)dodecanamide
|
88506-68-7
|
C50H92N2O18
|
|
N-[S-(2-PYRIDYLTHIO)CYSTEAMINYL]ETHYLENEDIAMINE-N,N,N',N'-TETRAACETIC ACID, MONOAMIDE
|
|
C17H24N4O7S2
|
|
N-[S-(2-PYRIDYLTHIO)CYSTEAMINYL]ETHYLENEDIAMINE-N,N,N',N'-TETRAACETIC ACID, MONOAMIDE, TECHNICAL GRAD
|
|
C17H28N8O4S2
|
|
N-[S-(2-Pyridylthio)cysteaminyl]ethylenediamine-N,N,N',N'-tetraacetic Acid, Monoamide
|
143541-95-1
|
C17H24N4O7S2
|
|
N-[(2S)-2-Pyrrolidinylmethyl]-trifluoromethanesulfonamide
|
782495-18-5
|
C6H11F3N2O2S
|
|
N-[(3S,4R)-1-(2-ethoxyethyl)-3-methyl-4-piperidyl]-N-phenyl-acetamide
|
125080-83-3
|
C18H28N2O2
|
|
N-[(3S,4R)-1-(2-ethoxyethyl)-3-methyl-4-piperidyl]-N-phenyl-propanamid e
|
125080-84-4
|
C19H30N2O2
|
|
N-[(3S,4R)-1-(2-ethoxyethyl)-3-methyl-4-piperidyl]-N-phenyl-benzamide
|
125080-85-5
|
C23H30N2O2
|
|
N-[(3S,4R)-1-(2-ethoxyethyl)-3-methyl-4-piperidyl]-N-phenyl-acetamide
|
125080-87-7
|
C18H28N2O2
|
|
N-[(3S,4R)-1-(2-ethoxyethyl)-3-methyl-4-piperidyl]-N-phenyl-benzamide
|
125080-89-9
|
C23H30N2O2
|
|
N-(THEXYLDIMETHYLSILYL)DIMETHYLAMINE
|
81484-86-8
|
C10H25NSi
|
|
N-[S-[(1R,2E,4Z)-1-[(1S)-1-Hydroxy-4-carboxybutyl]-2,4-pentadecadien-1-yl]-L-cysteinyl]glycine
|
|
C25H44N2O6S
|
|
|
NTG1 protein
|
|
|
|
|
Ntg2 protein
|
|
|
|
NU 2058
|
161058-83-9
|
C12H17N5O
|
|
NU7026
|
154447-35-5
|
C17H15NO3
|
|
NU 6027
|
220036-08-8
|
C11H17N5O2
|
|
NU6140
|
444723-13-1
|
C23H30N6O2
|
|
NU6102
|
444722-95-6
|
C18H22N6O3S
|
|
N-(1,3,4-Thiadiazolyl)nicotinamide
|
51987-99-6
|
C8H6N4OS
|
|
N~1~-1,3-thiazol-2-yl-beta-alaninamide(SALTDATA: 2HCl 0.8H2O)
|
1016878-45-7
|
C6H9N3OS
|